About RemovAid
RemovAid is a company based in Oslo (Norway) founded in 2012 by Marte Bratlie was acquired by Lifecare in April 2024. The company has 5 employees as of December 31, 2021. RemovAid offers products and services including RemovAid Device. RemovAid operates in a competitive market with competitors including Daré Bioscience, Aspivix, Femasys, Adiana and Uteron Pharma, among others.
- Headquarter Oslo, Norway
- Employees 5 as on 31 Dec, 2021
- Founders Marte Bratlie
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Removaid As
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RemovAid
RemovAid offers a comprehensive portfolio of products and services, including RemovAid Device.
Gentle, quick, needle-free tool for contraceptive implant removal.
Funding Insights of RemovAid
Investors in RemovAid
RemovAid has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include DNB and Lifecare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial banking services are provided to individuals and corporations.
|
Locked | Locked | Locked | |
|
Invasive app-based smart sensors for glucose monitoring are provided.
|
Locked | Locked | Locked |
Investor details for RemovAid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RemovAid
Investment portfolio details for RemovAid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RemovAid
Detailed financials for RemovAid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Removaid Comparisons
Peer comparison for RemovAid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RemovAid
RemovAid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daré Bioscience, Aspivix, Femasys, Adiana and Uteron Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-hormonal pharmaceutical products for female contraceptives are developed.
|
|
| Locked | Locked | Locked |
A next-generation suction-based cervical device for gynecology is provided.
|
|
| Locked | Locked | Locked |
Medical devices for women's healthcare are developed and provided.
|
|
| Locked | Locked | Locked |
Transcervical sterilization systems for permanent birth control are developed.
|
|
| Locked | Locked | Locked |
Develops products dedicated to female healthcare solutions.
|
Detailed competitors of RemovAid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Removaid
Complete news archive for RemovAid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RemovAid
RemovAid was founded in 2012 and raised its 1st funding round 6 years after it was founded.
RemovAid is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Kristin Sandereid is the current CEO of RemovAid.
As of Dec 31, 2021, the latest employee count at RemovAid is 5.
Annual revenue of RemovAid is $123.06K as on Dec 31, 2018.
RemovAid was founded in 2012 in Oslo, Norway, within the medical devices sector. Subdermal implants are addressed through the companys operations, which focus on proprietary patented technology for skin fixation, incision, and extraction. Devices for implant removal are provided to support clinical procedures. The ACCESS-CI product, intended as a contraceptive implant for womens birth control, is slated for launch in the near term.
RemovAid's top competitors include Daré Bioscience, Femasys and Aspivix.
RemovAid offers RemovAid Device.